Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
09/2012
09/18/2012US8268829 Substituted pyrimidines useful as protein kinase inhibitors
09/18/2012US8268819 Hexahydrooxazinopterine compounds
09/18/2012US8268786 Anti-cancer tocotrienol analogues and associated methods
09/18/2012US8268618 Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins
09/18/2012US8268617 Anti-IGF-I receptor antibodies, DNAs, vectors, host cells and genetic constructs
09/18/2012US8268591 Compositions and methods for producing inhibitors of vascular endothelial growth factor activity
09/18/2012US8268560 Polymide nucleic acid derivatives, and agents and processes for preparing them
09/18/2012US8268331 Nucleic acid molecules and polypeptides for immune modulation
09/18/2012US8268324 Modified galectin 9 proteins and use thereof
09/18/2012US8268319 Immunoconjugates with an intracellularly-cleavable linkage
09/18/2012US8268313 Methods for using inhibitors of vascular endothelial growth factor activity
09/18/2012US8268312 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
09/18/2012US8268308 Means for the diagnosis and therapy of CTCL
09/18/2012US8267982 Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant
09/18/2012CA2769991A1 Met inhibitors for enhancing radiotherapy efficacy
09/18/2012CA2603414C Anti-cd20 monoclonal antibody
09/18/2012CA2588417C 2-methylene-18,19-dinor-1.alpha.-hydroxy-homopregnacalciferol and its uses
09/18/2012CA2529742C Composition of a vegf antagonist and an anti-proliferative agent
09/18/2012CA2522326C Bifunctional tridentate pyrazolyl containing ligands for re, tc and mn tricarbonyl complexes
09/18/2012CA2521069C Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases
09/18/2012CA2503729C Novel cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs
09/18/2012CA2501717C Use of epothilone derivatives for the treatment of hyperparathyroidism
09/18/2012CA2490993C Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparations and uses thereof
09/18/2012CA2462610C Specific binding agents of human angiopoietin-2
09/18/2012CA2445746C Chimeric immunoreceptor useful in treating human cancers
09/18/2012CA2443302C Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles
09/18/2012CA2296750C Cellular vesicle called ''exosome'', preparation and use thereof in immune stimulation
09/13/2012WO2012122513A2 Generation of anti-fn14 monoclonal antibodies by ex-vivo accelerated antibody evolution
09/13/2012WO2012122471A2 Compounds and methods of use in ablative radiotherapy
09/13/2012WO2012122388A2 Chip-last embedded interconnect structures and methods of making the same
09/13/2012WO2012122368A1 Deoxycytidine kinase binding compounds
09/13/2012WO2012122106A2 Compositions and methods apc, creb, and bad pathways to assess and affect cancer
09/13/2012WO2012121764A1 Novel salts and polymorphic forms of afatinib
09/13/2012WO2012121679A1 Method of modulating phenotype of a renal cell cancer-associated monocyte or macrophage
09/13/2012WO2012121678A1 METHOD OF USING CD1d OVER-EXPRESSION IN HUMAN DENDRITIC CELLS TO ENHANCE CD8+ T CELL-BASED AND INVARIANT NATURAL KILLER T CELL- BASED ANTITUMOR IMMUNITY
09/13/2012WO2012121662A1 Novel pharmaceutical combinations and methods for treating cancer
09/13/2012WO2012121430A1 Carboxylic mannan-coated contrast agent for magnetic resonance imaging
09/13/2012WO2012121423A1 Pharmaceutical composition for preventing and treating complications of diabetes containing a traditional oriental medicine extract or a fraction thereof as an active ingredient
09/13/2012WO2012121361A1 Dispiropyrrolidine derivative
09/13/2012WO2012121178A1 Tumor angiogenesis inhibitor
09/13/2012WO2012121168A1 Kinase inhibitor
09/13/2012WO2012121058A1 Pharmaceutical composition that uses novel peptide that mimics tnf receptor loop peptide containing cross-linked structure
09/13/2012WO2012120469A1 Fluorophenyl bicyclic heteroaryl compounds
09/13/2012WO2012120428A1 Novel kinase inhibitors
09/13/2012WO2012120423A1 Pharmaceutical composition for the prevention or treatment of cancers
09/13/2012WO2012120415A1 Tetrasubstituted cyclohexyl compounds as kinase inhibitors
09/13/2012WO2012120004A1 In vivo selection of therapeutically active antibodies
09/13/2012WO2012119979A1 1H-PYROLLO[3,2-d]PYRIMIDINEDIONE DERIVATIVES
09/13/2012WO2012119787A1 Amatoxin-conjugates with improved linkages
09/13/2012WO2012119690A1 Pyrido [2, 3 - b] pyrazine derivatives and their therapeutical uses
09/13/2012WO2012119646A1 Method for reducing the risk of metastasis formation in cancerous diseases, and system for removing tumour cells from the blood circulation
09/13/2012WO2012119605A1 New disperse dye with potent anticancer activity
09/13/2012WO2012119559A1 Androgen receptor antagonists and uses thereof
09/13/2012WO2012119506A1 Indolone derivatives, pharmaceutical compositions thereof, and preparation methods and applications thereof
09/13/2012WO2012119458A1 Synthesis and use of antitumor drug lqc-y
09/13/2012WO2012119265A1 NOVEL ESTERS OF 4,9-DIHYDROXY-NAPHTHO[2,3-b]FURANS FOR DISEASE THERAPIES
09/13/2012WO2012087962A3 Anti-mesothelin antibodies and immunoconjugates
09/13/2012WO2012082470A3 The use anti-cxcl16 and anti-cxcr6 antibodies for the treatment or detecting cancer
09/13/2012WO2012078859A3 Protein kinase d inhibitors
09/13/2012WO2012078633A8 Methods of inhibiting metastasis from cancer
09/13/2012WO2012071383A9 Methods and compositions to eliminate chronic lymphocytic leukemia and other hematologic malignant cells in stromal microenvironment for cancer therapy
09/13/2012WO2012070905A3 Mollusk extract for preventing or treating rare and intractable diseases of the human body
09/13/2012US20120232463 De novo synthesis of bacteriochlorins
09/13/2012US20120232328 Drug activation system
09/13/2012US20120232148 Systems and Methods for Preventing Cancer and Treating Skin Lesions
09/13/2012US20120232135 (-)-Epigallocatechin Gallate Derivatives for Inhibiting Proteasome
09/13/2012US20120232134 Combination cancer therapy with bis(thiohydrazide) amide compounds
09/13/2012US20120232132 Rna antagonists targeting gli2 for the treatment of leukemia
09/13/2012US20120232126 Multi-targets interfering rna molecules and their applications
09/13/2012US20120232124 Compositions and methods for prognosis and treatment of prostate cancer
09/13/2012US20120232116 Novel fxr (nr1h4) binding and activity modulating compounds
09/13/2012US20120232107 Non-peptide antagonists of gastrin releasing peptide
09/13/2012US20120232103 Novel 5-fluorouracil derivative
09/13/2012US20120232102 Methods Of Administration And Treatment
09/13/2012US20120232100 Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
09/13/2012US20120232097 Cinnamoyl-piperazine derivatives and their use as par-1 antagonists
09/13/2012US20120232093 Pyrazole derivatives as sigma receptor inhibitors
09/13/2012US20120232088 Piperazinedione compounds
09/13/2012US20120232087 Methods and compositions for treating solid tumors and other malignancies
09/13/2012US20120232085 3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
09/13/2012US20120232082 Novel compounds and therapeutic use thereof for protein kinase inhibition
09/13/2012US20120232075 Fused Pyrazine Compounds Useful for the Treatment of Degenerative and Inflammatory Diseases
09/13/2012US20120232074 Imidazo [4, 5-C] Quinoline Derivatives As Bromodomain Inhibitors
09/13/2012US20120232072 Imidazopyridine derivatives
09/13/2012US20120232067 Benzodiazepinone compounds and methods of treatment using same
09/13/2012US20120232056 Heterocyclic compounds for the inhibition of pask
09/13/2012US20120232055 Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
09/13/2012US20120232054 Pyrrolotriazine compounds
09/13/2012US20120232052 Aryl carboxamide derivatives as ttx-s blockers
09/13/2012US20120232049 Pyridine or pyrimidine derivative having excellent cell growth inhibition effect and excellent anti-tumor effect on cell strain having amplification of hgfr gene
09/13/2012US20120232048 Method for modulating gpr119 g protein-coupled receptor and selected compounds
09/13/2012US20120232042 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylene phenyl derivatives, methods for the production thereof and use thereof for treating diseases
09/13/2012US20120232031 Injectable formulations for intra-articular or peri-articular administration
09/13/2012US20120232029 2',4'-substituted nucleosides as antiviral agents
09/13/2012US20120232018 Polycarbonates for delivery of drugs and methods of preparation thereof
09/13/2012US20120232011 Use of Rapamycin and Rapamycin Derivatives for the Treatment of Bone Loss
09/13/2012US20120232010 Compositions and Methods for Treating Bladder Cancer
09/13/2012US20120231097 Medicinal composition and usage
09/13/2012US20120231090 Molecular biomarker set for early detection of ovarian cancer
09/13/2012US20120231085 Controlled release compositions of gamma-hydroxybutyrate
1 ... 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 ... 2211